The Utility of CD43 and CD200 in Differentiating Chronic Lymphocytic Leukemia from Other Mature B-Cell Neoplasms: A Cross Sectional Study.

MLA

Kannan, Narasimhapriyan, et al. “The Utility of CD43 and CD200 in Differentiating Chronic Lymphocytic Leukemia from Other Mature B-Cell Neoplasms: A Cross Sectional Study.” Indian Journal of Hematology & Blood Transfusion, vol. 40, no. 3, July 2024, pp. 437–42. EBSCOhost, https://doi.org/10.1007/s12288-023-01719-1.

APA

Kannan, N., Dass, J., Parikh, H., Tiwari, S., Viswanathan, G. K., Aggarwal, M., Kumar, P., Dhawan, R., Seth, T., Tyagi, S., & Mahapatra, M. (2024). The Utility of CD43 and CD200 in Differentiating Chronic Lymphocytic Leukemia from Other Mature B-Cell Neoplasms: A Cross Sectional Study. Indian Journal of Hematology & Blood Transfusion, 40(3), 437–442. https://doi.org/10.1007/s12288-023-01719-1

Chicago

Kannan, Narasimhapriyan, Jasmita Dass, Himil Parikh, Sarjana Tiwari, Ganesh Kumar Viswanathan, Mukul Aggarwal, Pradeep Kumar, et al. 2024. “The Utility of CD43 and CD200 in Differentiating Chronic Lymphocytic Leukemia from Other Mature B-Cell Neoplasms: A Cross Sectional Study.” Indian Journal of Hematology & Blood Transfusion 40 (3): 437–42. doi:10.1007/s12288-023-01719-1.